Alan S. Nies is Director at LEXICON PHARMACEUTICALS, INC./DE (LXRX). They have made 1 open-market trade across 1 company since 2007, most recently 2023-05-21.
CIK 0001270260
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $15K since 2007, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LXRX | 41,046 | $66K |
Shares reported on the most recent Form 4, priced at the 2023-05-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LXRX | BUY | 2007-12-19 | 2007-12-20 | $2.98 | $15K | -21.0% | +0.6% | +0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.